Methemoglobinemia and hemolysis in a patient with G6PD deficiency treated with rasburicase
- 10 May 2012
- journal article
- case report
- Published by Wiley in American Journal of Hematology
- Vol. 88 (2) , 152-154
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Methemoglobinemia and hemolytic anemia after rasburicase administration in a child with leukemiaInternational Journal of Clinical Pharmacy, 2011
- Control of Plasma Uric Acid in Adults at Risk for Tumor Lysis Syndrome: Efficacy and Safety of Rasburicase Alone and Rasburicase Followed by Allopurinol Compared With Allopurinol Alone—Results of a Multicenter Phase III StudyJournal of Clinical Oncology, 2010
- Tumor Lysis Syndrome and Acute Kidney Injury: Evaluation, Prevention, and ManagementAmerican Journal of Kidney Diseases, 2010
- Exchange transfusion as treatment for rasburicase induced methemoglobinemia in a glucose‐6‐phosphate dehydrogenase deficient patientPediatric Blood & Cancer, 2008
- Guidelines for the Management of Pediatric and Adult Tumor Lysis Syndrome: An Evidence-Based ReviewJournal of Clinical Oncology, 2008
- Methemoglobinemia and hemolytic anemia caused by rasburicase administration in a newly diagnosed child with Burkitt lymphoma/leukemiaPediatric Blood & Cancer, 2007
- Ascorbate removes key precursors to oxidative damage by cell-free haemoglobin in vitro and in vivoBiochemical Journal, 2006
- Report of two cases of rasburicase-induced methemoglobinemiaLeukemia & Lymphoma, 2006
- Tumour lysis syndrome: new therapeutic strategies and classificationBritish Journal of Haematology, 2004
- Renal complications of neoplastic diseaseJournal of Chronic Diseases, 1963